"Pecos" B-adrenergic and PPAR-G Stimulation Upregulates Lipid Metabolism in Human Subcutaneous Fat
Status:
Completed
Trial end date:
2004-11-01
Target enrollment:
Participant gender:
Summary
This study compares four treatments to see which one causes the most weight loss, fat loss,
loss of abdominal fat and improvement in blood tests like cholesterol. The four treatments
are: Placebo, Ephedrine plus caffeine, Pioglitazone, Combined pioglitazone and ephedrine plus
caffeine